ISO-1
CAS No. 478336-92-4
ISO-1( ISO-1 | ISO 1 | ISO1 | MIF Antagonist )
Catalog No. M17520 CAS No. 478336-92-4
ISO-1 is an inhibitor of the dopachrome tautomerase activity, blocks the activation of NF-κB and TNF-α secretion from LPS-treated macrophages.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 165 | In Stock |
|
| 50MG | 290 | In Stock |
|
| 100MG | 462 | In Stock |
|
| 500MG | 788 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameISO-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionISO-1 is an inhibitor of the dopachrome tautomerase activity, blocks the activation of NF-κB and TNF-α secretion from LPS-treated macrophages.
-
DescriptionISO-1, also known as MIF Antagonist and ISO-1 and Macrophage Migration Inhibitory Factor, is a MIF inhibitor. ISO-1 has CAS#478336-92-4. MDK-6924 Protects Photoreceptors and Reduces Gliosis in Experimental Retinal Detachment. Systemic administration of the MIF inhibitor ISO-1 significantly blocked photoreceptor apoptosis, outer nuclear layer (ONL) thinning, and retinal gliosis. ISO-1 and MIF knockout (MIFKO) had greater accumulation of Müller glia pERK expression in the detached retina, suggesting that Müller survival pathways might underlie the neuroprotective response.
-
In VitroISO-1 (0.1-20 μM; 16 hours) has a slight inhibitory effect on Cox-2 secretion without the addition of recombinant MIF. Western Blot Analysis Cell Line:RAW 264.7 macrophage cells Concentration: 0.1μM, 1μM,10μM,20μM Incubation Time:16 hours Result:SuppressedCox-2 secretion.
-
In VivoISO-1 (injected intraperitoneally; 3.5-35 mg/kg; twice daily; 2 weeks) improves the survival rate from lethal endotoxemia and shows the anti-inflammatory effect.ISO-1 (intraperitoneal injection; 35 mg/kg; twice daily; 3 days) causes a significant reduction in average implant size and decreases Flk1 expression in implants. Animal Model: C57Bl/6 MIF+/+ and MIF–/– mice Dosage:3.5-35 mg/kg Administration:Injected intraperitoneally; 3.5-35 mg/kg; twice a day ; 2 weeks Result:Was protective against lethal sepsis.Animal Model:Female C57BL/6-Tg(ACTB-EGFP)1Osb/J mice Dosage:35 mg/kg Administration:Intraperitoneal injection; 35 mg/kg; twice daily; 3 daysResult:Reduced average endometriotic implant size.
-
SynonymsISO-1 | ISO 1 | ISO1 | MIF Antagonist
-
PathwayOthers
-
TargetOther Targets
-
RecptorMIF
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number478336-92-4
-
Formula Weight235.2
-
Molecular FormulaC12H13NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 36 mg/mL; 153.04 mM
-
SMILESCOC(=O)CC1CC(=NO1)c1ccc(O)cc1
-
Chemical Name4,5-dihydro-3-(4-hydroxyphenyl)-5-isoxazoleacetic acid, methyl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xu L, et al. Drug Discov Today. 2013 Jun;18(11-12):592-600.
molnova catalog
related products
-
L-Homocitrulline
Homocitrulline is a metabolite that can be detected in larger amounts in the urine of individuals with urea cycle disorders. The accumulation of carbamyl phosphate due to a depleted supply of ornithine for the urea cycle may be responsible for the enhanced synthesis of homocitrulline and homoarginine in some cases.
-
Levistilide A
Levistilide A inhibits liver fibrosis and angiogenesis.
-
Methyl (2R,3S)-3-(be...
Medical intermediate.
Cart
sales@molnova.com